MedTrace Logo

Endurant Evo International Clinical Trial

NCT02461524 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2024-04-01

Study results available
· View outcomes & findings →

Summary

The purpose of this trial is to evaluate the safety and effectiveness of the Endurant Evo Abdominal Aortic Aneurysm (AAA) Stent graft system for endovascular treatment of subjects with infrarenal abdominal aortic or aortoiliac aneurysms.

Conditions

  • Abdominal Aortic Aneurysm
  • AAA

Interventions

DEVICE

Endurant Evo AAA Stent Graft System

PROCEDURE

Endovascular aneurysm repair (EVAR)

Sponsors & Collaborators

  • Medtronic Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Hence Verhagen, MD, PhD · Erasmus Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2021-06-25
Completion
2021-06-25

Countries

  • Austria
  • Belgium
  • Denmark
  • Netherlands
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02461524 on ClinicalTrials.gov